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ABSTRACT
Background: Cerebral toxoplasmosis (CT) continues to cause significant morbidity and mortality 
in human immunodeficiency virus (HIV)-infected patients in Brazil. In clinical practice, the initial 
diagnosis is usually presumptive and alternative diagnosis tools are necessary. Our objective was to 
evaluate whether the detection of high titers of IgG anti-Toxoplasma gondii and T. gondii DNA in 
blood samples are associated with the diagnosis of CT. Methods: In this case-control study we 
included 192 patients with HIV-1 infection: 64 patients with presumptive CT (cases) and 128 pa-
tients with other diseases (controls). Blood samples to perform indirect immunofluorescense 
reaction (IFI) to detect anti-T. gondii IgG antibodies and polymerase chain reaction (PCR) were 
collected before or within the first three days of anti-Toxoplasma therapy. Two multivariate logis-
tic regression models were performed: one including the variable qualitative serology and another 
including quantitative serology. Results: In the first model, positive IgG anti-T. gondii (OR 4.7, 95% 
CI 1.2-18.3; p = 0.027) and a positive T. gondii PCR result (OR 132, 95% CI 35-505; p < 0.001) were 
associated with the diagnosis. In the second model, IgG anti-T. gondii titres ≥ 1:1024 (OR 7.6, 95% 
CI 2.3-25.1; p = 0.001) and a positive T. gondii PCR result (OR 147, 95% CI 35-613; p < 0.001) 
were associated with the diagnosis. Conclusions: Quantitative serology and molecular diagnosis in 
peripheral blood samples were independently associated with the diagnosis of CT in HIV-infected 
patients. These diagnostic tools can contribute to a timely diagnosis of CT in settings where Toxo-
plasma infection is common in the general population. 
Keywords: toxoplasmosis; cerebral toxoplasmosis; polymerase chain reaction; diagnosis; acquired 
immunodeficiency syndrome; Brazil.
INTRODUCTION
The introduction of highly active antiretroviral 
therapy (HAART) has resulted in a dramatic 
reduction of the incidence of acquired immu-
nodeficiency syndrome (AIDS)-related cerebral 
toxoplasmosis (CT) in developed countries.1 
Similarly, an important decrease in case 
reports have been observed in São Paulo in 
the HAART era. Nevertheless, CT continues 
to cause important mortality and morbidity 
in our settings.2 In clinical practice, presump-
tive diagnosis of CT is based on clinical and 
radiological features associated to successful 
response within 14 days of specific treatment.3,4 
On the other hand, definitive diagnosis using 
biological tools (intraperitoneal inoculation 
to laboratory animals or inoculation to cell 
cultures in vitro) showed low sensitivity5 and 
brain biopsy has complications and elevated 
costs.6 Thus, alternative approaches for a timely 
diagnosis are necessary. In recent years, mo-
lecular diagnosis of CT in cerebrospinal fluid 
(CSF) and peripheral blood samples had sig-
nificant improvement,5 but has not produced 
conclusive results.4 Here, we evaluated whether 
detection of high titers of IgG anti-Toxoplasma 
gondii and T. gondii DNA in blood samples 
could be used to diagnose CT.
PATIENTS AND METHODS
All patients were admitted to Instituto de Infec-
tologia Emílio Ribas, a referral tertiary hospital 
in São Paulo, Brazil. This case-control study 
included 192 patients with HIV-1 infection 
documented by antibody enzyme-linked im-
munosorbent assay (ELISA) and Western Blot 
tests: 64 patients with presumptive cerebral tox-
oplasmosis (cases) and 128 patients with other 
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diseases (controls). Cases were defined as follows: I) recent 
onset of a consistent focal neurological abnormality with 
intracranial disease or reduced level of consciousness; II) a 
lesion having a mass effect evidenced by brain imaging (on 
computed tomography or magnetic resonance) or a lesion 
whose radiographic appearance was enhanced by injection 
of contrast medium, and III) successful response to the spe-
cific treatment. The control group consisted of 128 patients 
with other diseases. Sixty-four presented with neurological 
diseases: 25 with cryptococcal meningoencephalitis, 7 with 
progressive multifocal leukoencephalopathy, 14 with central 
nervous system (CNS) tuberculosis, 12 with HIV-associated 
neurocognitive disorders, and six with syphilitic meningitis. 
The other 64 patients presented with non-neurological dis-
eases: 18 with pulmonary tuberculosis, 12 with bacterial 
pneumonia, seven with oral candidiasis, five with diffuse lym-
phoma, and 22 with Pneumocystis jiroveci pneumonia. Blood 
samples to perform indirect immunofluorescense reaction 
(IFI) to detect anti-T. gondii IgG antibodies and polymerase 
chain reaction (PCR) were collected before or within the first 
three days of anti-Toxoplasma therapy. IgG T. gondii titers 
≥ 1:16 and ≥ 1:1024 were considered positive and high, re-
spectively. The samples were analyzed by conventional PCR 
targeting a 115-base-pair sequence in a specific repetitive re-
gion of the B1 gene of T. gondii. PCR and IFI methodologies 
were reported elsewhere.7
For statistical analysis, the outcome variable in the present 
study was the diagnosis of CT. Univariate logistic regression 
analysis was performed to identify the independent variables 
that were associated with the diagnosis of CT. The list of po-
tential variables included age, gender, prior CT, lymphocyte 
T-CD4+ cell count, use of CT prophylaxis at admission, posi-
tive IgG anti-T. gondii IFI, high titers of IgG anti-T. gondii IFI, 
and a positive PCR result for T. gondii DNA in blood sam-
ples. Only those variables with a p-value ≤ 0.2 were included 
in the multivariate analysis. Variables with a p-value ≤ 0.05 
remained in the final multivariate logistic regression model. 
Correlations between qualitative serology (IFI ≥ 1:16) and 
quantitative serology (≥ 1:1024), and between quantitative se-
rology (≥ 1:1024) and a positive T. gondii PCR were calculated 
with the nonparametric correlation Spearman’s test. Statistical 
analysis was performed using SPSS software 10.0 (SPSS Inc. 
Product Registration, Chicago, USA, 1999). This study was 
approved by the institutional review board of Instituto de In-
fectologia Emílio Ribas.
RESULTS 
The serological prevalence of T. gondii infection in the patients 
included in this study was 68% [58/64 (91%) of cases and 
72/128 (56%) of controls (p < 0.001)]. When only patients with 
a positive result of IgG anti-T. gondii IFI we compared, cases 
(52/58, 90%) presented more frequently high IgG titers than 
controls (39/72, 54%) (p < 0.001).
According to the primary criteria in univariate analysis 
(Table 1), the following variables were associated with the 
Table 1. Univariate analysis for the identification of independent variables associated with the diagnosis of 
cerebral toxoplasmosis 
Variable Cases (n = 64) Controls (n = 128) OR (95% CI) p
Age (years)  
 Mean ± SD 35.9 ± 9.5 35.8 ± 7.7 1.0 (0.9-1.0) 0.902
Gender 
 Male 37 78 
 Female 27 50 
0.9 (0.5-1.6) 0.677
Previous cerebral toxoplasmosis 
 Yes 11 16 
 No 53 112 
1.5 (0.6-3.4) 0.380
CD4 T-cell count (cells/μL)  
 Mean ± SD 71.4 ± 72.9 61.5 ± 0.6 1.0 (0.9-1.0) 0.284
Use of prophylaxis at admission 
 Yes 3 23 
 No 61 105 
0.2 (0.1-0.8) 0.019
IgG anti-T. gondii 
 ≥ 1:16 58 72 
 < 1:16  6 56 
7.5 (3.0-18.7) < 0.001
IgG anti-T. gondii  
 ≥ 1:1024 52 41 
 < 1:1024 12 87 
9.2 (4.4-19.1) < 0.001
T. gondii PCR in blood 
 Positive 51 3  
 Negative 13 125 
163 (45-597) < 0.001
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diagnosis of CT: no use of CT prophylaxis at admission, IgG 
anti-T. gondii IFI ≥ 1:16 or IgG anti-T. gondii IFI ≥ 1:1024, 
and a positive T. gondii PCR result. Nonparametric corre-
lations between qualitative and quantitative serology were 
high (p < 0.001). For this reason, were designed two multi-
variate logistic regression models: one including the varia-
ble qualitative serology and another including quantitative 
serology. In the first case, only positive T. gondii IFI [OR 
4.7, 95% CI 1.2-18.3; p = 0.027] and a positive T. gondii 
PCR result [OR 132, 95% CI 35-505; p < 0.001] remained 
in the final model. In the latter model, only IgG T. gondii 
IFI ≥ 1:1024 [OR 7.6, 95% CI 2.3-25.1; p = 0.001] and a 
positive T. gondii PCR result [OR 147, 95% CI 35-613; 
p < 0.001] remained in the final model. In addition, 
nonparametric correlations between qualitative serology and 
a positive T. gondii PCR result, and quantitative serology 
and a positive T. gondii PCR result were high (p < 0.001). 
DISCUSSION
The main finding of our study, performed in a setting with 
high prevalence of Toxoplasma infection in the general pop-
ulation, was the significant association between high IgG 
anti-T. gondii titers and PCR detection of T. gondii DNA in 
peripheral blood samples and the diagnosis of CT.
Cerebral toxoplasmosis is the most frequent CNS op-
portunistic infection in HIV-infected patients in Brazil.8,9 
In a previous report, we observed that CT accounts for 
10% of the admissions at Instituto de Infectologia Emí-
lio Ribas, usually occurring as AIDS-defining disease.2 
In addition, similarly to other reports,10 CT continue to ap-
pear in Brazil among patients with late HIV diagnosis, with 
poor compliance with HAART, or with treatment failure. 
In the present study, we identified that non-compliance 
with CT prophylaxis at admission was predictive of CT in uni-
variate analysis. The benefit of prophylaxis is well described in 
the literature; therefore, it is possible that this variable did not 
remain significant when included in the multivariate analysis 
due to the low proportion of controls using antibiotic pro- 
phylaxis at admission. Classically, positive IgG T. gondii serol-
ogy has been considered in the diagnosis of CT.11 In a large 
study, Raffi et al.12 reported a trend towards higher median IgG 
anti-T. gondii titers in patients with CT (p = 0.08). However, 
only qualitative T. gondii serology, but not the quantitative one, 
was associated to the diagnosis of CT. In accordance with stud-
ies that showed the predictive value of high IgG anti-T. gondii 
titers,13,14 our results showed an independent association be-
tween high titers of IgG anti-T. gondii and the diagnosis of 
CT. This association could reflect the direct effect of qualita-
tive serology, as it was demonstrated with the high correlation 
between qualitative and quantitative serologies. Nevertheless, 
when we analyzed only the patients with a positive serology, 
cases had a frequency of elevated IgG titers higher than con-
trols, suggesting the additional value of quantitative serology.
Available studies of PCR using peripheral blood in HIV-
related CT and usually performed with conventional PCR 
protocols and small number of subjects, reported sensitivi-
ties ranging from 13% to 88% with specificity ≥ 95%.5,15 Re-
cently, we reported our experience with conventional PCR 
assay using peripheral blood samples in patients with AIDS-
related CT, showing a sensitivity of 80% and a specificity 
of 98%.7 These very divergent results can be due, at least in 
part, to several reasons: choice of target DNA and primers, 
PCR techniques, conditions and time of sample storage, 
and collection of blood samples before or in the first days 
after introduction of specific treatment.5,15,16 It was reported 
that genotypes of T. gondii strains isolated from patients 
with ocular toxoplasmosis in Brazil were highly divergent 
when compared to the previously described clonal lineages 
from North America and Europe, suggesting more frequent 
sexual recombinants resulting in mixed genotypes.17 Simi-
larly, our group showed the high rate of genetic exchange in 
T. gondii strains isolated from HIV-infected patients with 
CT.18 Future studies should evaluate the relation between 
genetic diversity, parasitic burden, molecular diagnosis and 
clinical outcomes in AIDS patients with CT.
Introduction of real-time PCR and automated DNA 
extraction could avoid some limitations of conventional 
PCR and perform a more accurate and timely diagnosis.15 
A recent report of our group found high sensitivity of real-
time quantitative PCR, in CT diagnosis, using two different 
primer sets (B1Tg, which amplified a sequence from the B1 
gene and RETg, which amplified a PCR product of the 529 
base pairs sequence).19
Reinforcing the importance of molecular diagnosis us-
ing peripheral blood samples in immunedeficient patients, 
a study of patients with allogenic stem cell transplantation 
suggested that quantitative PCR assay may guide preemptive 
therapy and avoid death due to toxoplasmosis in about 80% 
of patients who develop infection.20
International recommendations of diagnosis and man-
agement of expansive brain lesions in HIV-infected patients 
consider primary CNS lymphoma (PCNSL) as the second 
most frequent opportunistic disease in developed coun-
tries.4,21 However, PCNSL is uncommon in most develop-
ing countries, where focal forms of CNS tuberculosis (i.e. 
tuberculomas) are the main differential diagnosis of CT.22,23 
Furthermore, the clinical and radiological differentiation 
between these opportunistic infections poses important 
challenges in resource-limited settings, where both infec-
tions are highly prevalent in the general population and al-
ternative and timely diagnosis approach are necessary.24 
In accordance with a previous study carried out in a 
middle-income country, our findings demonstrate that PCR 
is a relatively simple and rapid procedure that can be per-
formed in developing countries with reasonable laboratory 
infrastructure.25 The results of the present study highlight 
Diagnosis of AIDS-related cerebral toxoplasmosis
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the importance of considering quantitative serology and 
molecular diagnosis in peripheral blood samples in the ini-
tial management of HIV-infected presenting with expansive 
brain lesions. In this line, a recent algorithm incorporated 
these tools.26 
In conclusion, our results suggest that high IgG anti-
Toxoplasma titers and a positive PCR result for of T. gondii 
DNA in blood samples were significantly associated with 
CT in AIDS patients. These diagnostic tools must be inter-
preted in association with clinical and radiological infor-
mation, and can contribute to a timely diagnosis, especially 
in Brazil and in other low and middle-income countries 
with high prevalence rates of Toxoplasma infection in the 
general population. 
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